INDAPTUS THERAPEUTICS INC (INDP) Forecast, Price Target & Analyst Ratings
NASDAQ:INDP • US45339J2042
2.01 USD
+0.13 (+6.91%)
Last: Mar 4, 2026, 08:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INDAPTUS THERAPEUTICS INC (INDP).
Forecast Snapshot
Consensus Price Target
$10.20
+ 407.46% Upside
Next Earnings Forecast
Release DateMar 10, 2026
PeriodQ4 / 2025
EPS Estimate-$4.45
Revenue Estimate
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$10.20
Upside
+ 407.46%
From current price of $2.01 to mean target of $10.20, Based on 7 analyst forecasts
Low
$10.10
Median
$10.20
High
$10.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 analysts have analysed INDP and the average price target is 10.2 USD. This implies a price increase of 407.46% is expected in the next year compared to the current price of 2.01.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
INDP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about INDP.
In the previous month the buy percentage consensus was at a similar level.
INDP was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-13 | Maxim Group | Maintains | Buy -> Buy |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-20 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-08 | HC Wainwright & Co. | Reiterate | Overweight |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-10-19 | Maxim Group | Upgrade | Hold -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 10, 2026
PeriodQ4 / 2025
EPS Estimate-$4.45
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q58.20%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
INDP is expected to report earnings on 3/10/2026. The consensus EPS estimate for the next earnings is -4.45 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 190.28% | N/A 67.52% | N/A 63.90% | N/A 31.49% | |||||||||||
| EBITDA YoY % growth | -6.85M | -13.14M -91.82% | -28.61M -117.73% | -42.47M -48.44% | -32.6M 23.24% | -12.63M 61.26% | -7.73M 38.80% | -14.91M -92.88% | -16.377M -9.84% | -15.365M 6.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.6M | -13.84M -82.11% | -29.44M -112.72% | -43.33M -47.18% | -33.45M 22.80% | -13.83M 58.65% | -7.73M 44.11% | -14.91M -92.88% | -16.378M -9.85% | -15.366M 6.18% | N/A -6.40% | N/A -26.71% | N/A -3.15% | N/A 138.47% | N/A 708.92% | N/A 92.76% | N/A 80.37% | N/A 37.84% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2,620.80 -20.11% | N/A -7.23% | -3,136.00 -11.59% | -2,508.80 20.00% | -456.96 81.79% | -291.20 36.27% | -48.44 83.37% | -51.80 -6.94% | -45.36 12.43% | N/A 42.79% | N/A 74.72% | N/A 30.33% | N/A 122.54% | N/A 833.66% | N/A -31.92% | N/A 70.56% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -4.45 58.20% | -1.91 78.71% | -1.60 82.38% | -1.49 50.03% | -1.55 65.14% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.438M -6.39% | -4.764M -4.19% | -4.971M -11.55% | -5.386M -103.35% | -5.593M -26.02% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
23.84%
EPS Next 5 Year
17.21%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
INDAPTUS THERAPEUTICS INC / INDP Forecast FAQ
Can you provide the average price target for INDAPTUS THERAPEUTICS INC stock?
7 analysts have analysed INDP and the average price target is 10.2 USD. This implies a price increase of 407.46% is expected in the next year compared to the current price of 2.01.
What is the next earnings date for INDP stock?
INDAPTUS THERAPEUTICS INC (INDP) will report earnings on 2026-03-10, after the market close.
Can you provide the consensus estimates for INDAPTUS THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of INDAPTUS THERAPEUTICS INC (INDP) is -4.45 USD and the consensus revenue estimate is 0 USD.
How many analysts cover INDAPTUS THERAPEUTICS INC (INDP) stock?
The number of analysts covering INDAPTUS THERAPEUTICS INC (INDP) is 7.